Article Sidebar
Published:
Apr 28, 2004Keywords:
Piroxicam Qualitative Quantitative Evaluation
Article Details
Issue
Section
Articles
OPEN ACCESS STATEMENT
All articles published by Bio-Research journal are made immediately available worldwide under an open access license. This means:
- Everyone has free and unlimited access to the full-text of all articles published in Bio-Research journal;
- Everyone is free to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose.
- Open access publication is supported by the authors' institutes or research funding agencies by payment of a comparatively low Article Processing Charge (APC) for accepted articles.
Permissions
No special permission is required to reuse all or part of article published by Bio-Research, including figures and tables. For articles published under an open access Creative Common CC BY-NC-ND 4.0 license, any part of the article may be reused without permission provided that the original article is clearly cited. Reuse of an article does not imply endorsement by the authors or Bio-Research.
Notices
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
Main Article Content
Qualitative and Quantitative Evaluation of Multi-source Piroxicam Capsules Available in Nigeria
Abstract
The qualitative and quantitative evaluation of eleven brands of piroxicam capsules marketed in Nigeria is presented. The disintegration time, dissolution rate and absolute drug content were determined in simulated intestinal fluid (SIF) and simulated gastric fluid (SGF) without enzymes. Weight uniformity test was also performed according to official methods. Data obtained from the dissolution profiles in both media (SIF and SGF) were mathematically treated according to the model proposed by Khan (with slight modification) and the resulting predicted availability equivalent (PAE) was used to quantitatively assess/ predict bioavailability of piroxicam from the various brands. Our results indicate variable PAE with pH. In SGF, four out of the eleven (11) brands could be adjudged to be bioequivalent with the innovator drug, Feldene (Neimeth, Nigeria); In SIF, only three out of the eleven (11) were equivalent with the innovator drug. All the capsules (except one brand) generally disintegrated within 15 min. in both SIF and SGF. The weights were also very uniform with insignificant variations. However, the variation in absolute drug contents were generally wide, with all the capsules having drug contents that are above the label claim
Key Words: Piroxicam, Qualitative, Quantitative Evaluation
Bio-Research Vol.1(2) 2003: 101-110
Key Words: Piroxicam, Qualitative, Quantitative Evaluation
Bio-Research Vol.1(2) 2003: 101-110
